SCAI 2026 Bifurcation PCI Reimagined: Data-Driven Decisions in Complex Anatomy

How to Register

To register, press the "Login" or "Register" button on the right.
Sign in with your scai.org username and password. If you don't have an account, click “Set Up Your Login.”

Faculty

	Yiannis S. Chatzizisis, MD, PhD, FSCAI Moderator, The Bifurcation Playbook: Best Practices Shaping Tomorrow’sGuidelines		George D. Dangas,MD, PhD, MSCAI Moderator
	Vladimír Džavík, MD, FSCAI DCB in Bifurcation PCI		Tanveer Rab, MD, MSCAI 0-0-1 PCI
	Yader B. Sandoval, MD, FSCAI CT-Guided Bifurcation PCI		Alaide Chieffo, MD, FSCAI Panelist

Learning Objectives

At the end of this activity, participants should be able to:

1. Review an algorithmic approach to PCI in bifurcated lesions.

2. Describe the role of intracoronary imaging and CT in bifurcation PCI.

3. Evaluate drug-coated balloons in treating bifurcated lesions.

Acknowledgement of Commercial Support

This activity is supported by an unrestricted educational grant from Boston Scientific.

Disclosures

Individuals in control of content reported the following relevant financial relationships with ineligible companiesduring the content development process for this activity. All relevant financial relationships were mitigated beforethe start of the activity.

Planner & Faculty
Yannis Chatzizisis: Advisory Board and Consulting with Medtronic.

Faculty
George Dangas, Vladimír Džavík, and Tanveer Rab: No financial relationships with ineligible companies

Alaide Chieffo: Advisory Board and Consulting with Medtronic.

Yader Sandoval: Consulting with Abbott. Consulting with Boston Scientific Corp. Speaker Bureau with CathWorks. Speaker Bureau with Cleerly. Consulting with GE Healthcare. Consulting with Heartfllow. Consulting with Philips. Consulting with Siemens Healthineers. PI with Shockwave Medical.

Reviewer
Andrew Klein: No financial relationships with ineligible companies

SCAI Staff
Laura Porter: No financial relationships with ineligible companies

Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation
SCAI designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.5 MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Watch the content and complete the evaluation to obtain credit.

SCAI's Independent Content

As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.

Planning Process
SCAI activities are developed by the SCAI Planners prior to and independent of commercial support. Members of the Annual Meeting Program Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.

Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI any relevant financial relationships. SCAI identifies relevant financial relationships and mitigates them before the activity begins.

Content Validation Statement

SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis.

SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients.

SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company.

SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. 

SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.

Summary

Availability:

On-Demand

Access expires on Apr 30, 2027

Cost:

FREE

Credit Offered:

1.5 CME Credits

1.5 ABIM-MOC Points

1.5 Participation Credits